Helogen

$7M SeedRaised yesterdayNYC, USABiotech & PharmaUSA
Visit website →

Why now

Where Helogen is today

Helogen announced a funding round of $7M on 4 September 2026, led by RRE Ventures and Oceans.

Latest round
Seed
Amount
$7M
Announced
4 September 2026
Headquarters
NYC, USA
Sector
Biotech & Pharma
Investors
RRE Ventures and Oceans
Also participating
One Way Ventures and Blisce
Relevant leadership
Not stated

Momentum AfterRaise intelligence

AfterRaise Score

58
Steady growth
1 funding signal in the last 90 days
Funding recency
40/40
announced within the last 30 days
Round scale
8/25
round size relative to the market
Funding stage
10/20
Seed
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

In their own words

What Helogen says it is doing

Work here? Add to this

Public signal Described in the funding announcement as "space biotechnology and in-orbit manufacturing startup". Source

Manufacturing and scale

Public signal Read from the company's own description of what the funding supports.

Since the raise

What has happened since

  • 4 September 2026
    $7M Seed
    Led by RRE Ventures and Oceans.

Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

What happens next

What this raise plausibly creates

AfterRaise inferenceAfterRaise intelligence

Likely next Moves

  • Manufacturing capacity expansion
  • Senior operations hiring
  • Supply-chain build-out
  • Founding team growth

Opportunities this could create

  • CMC and manufacturing
  • Quality systems
  • Licensing and BD partnerships
  • Manufacturing leadership
  • Supply-chain partners

Based on the Biotech & Pharma sector, a Seed round and the priorities the company itself set out. Not a statement of fact.

Medium momentum2 connected signals
  • 4 September 2026$7M Seed announced
  • 4 September 2026Stated priority: manufacturing and scale

High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.

Open to

What Helogen is open to

Not yet specified

Helogen has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Opportunities

Ways to work with Helogen

All opportunities
OpportunityJOBPublic signal22 days ago
Helogen
Los Angeles

Founding Marketing Lead

Helogen is hiring for this role on its own job board, after raising $7M.

Who they want
Approach preferences not yet specified
Apply on Helogen’s site →Company page
OpportunityJOBPublic signal25 days ago
Helogen
Los Angeles

Mechanical Engineer II

Helogen is hiring for this role on its own job board, after raising $7M.

Who they want
Approach preferences not yet specified
Apply on Helogen’s site →Company page
OpportunityJOBPublic signal3 months ago
Helogen
Los Angeles

Lead Vehicle Design Engineer

Helogen is hiring for this role on its own job board, after raising $7M.

Who they want
Approach preferences not yet specified
Apply on Helogen’s site →Company page

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Work here?

Your company is growing. Tell people what you need next.

This page belongs to Helogen. Claim it to say where you are going, correct anything AfterRaise got wrong, publish the work you have open, and choose who may approach you. Companies are more protected after claiming, not less: you decide what kinds of approach you want, and we refuse the rest.

What we do not have yet: who leads the team. Claiming the page is how you fill those in.

Also moving

Other Biotech & Pharma companies

See the sector